DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma

por Eason, Anthony B., Sin, Sang-Hoon, Shah, Mohsin, Yuan, Hong, Phillips, Douglas J., Droste, Miriam, Shamshiev, Abdijapar, Dittmer, Dirk P.
Publicado 2020